MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

A

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

Search

Quidel Corp

Fermé

30.21 1.44

Résumé

Variation du prix de l'action

24h

Actuel

Min

29.42

Max

30.27

Chiffres clés

By Trading Economics

Employés

6,600

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+51.06% upside

Dividendes

By Dow Jones

Prochains Résultats

30 juil. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-89M

1.7B

Ouverture précédente

28.77

Clôture précédente

30.21

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 juil. 2025, 17:03 UTC

Principaux Mouvements du Marché

Furniture Companies Rise on U.S. Trade Deal With Vietnam

2 juil. 2025, 15:18 UTC

Principaux Mouvements du Marché

Mogo Shares Rally After Embrace of Bitcoin Into Holdings, Operations

2 juil. 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

2 juil. 2025, 23:45 UTC

Market Talk

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

2 juil. 2025, 23:40 UTC

Market Talk

Gold Edges Lower Amid Hopes for More Trade Deals -- Market Talk

2 juil. 2025, 21:01 UTC

Acquisitions, Fusions, Rachats

AT&T Completes Sale of Entire Remaining 70% Stake in DIRECTV to TPG >T

2 juil. 2025, 21:01 UTC

Acquisitions, Fusions, Rachats

AT&T and TPG Close DIRECTV Transaction

2 juil. 2025, 20:26 UTC

Résultats

Rivian Stock Drops on Sales Decline. The Stakes Are High for the Rest of 2025. -- Barrons.com

2 juil. 2025, 20:22 UTC

Market Talk

Gold Rises Following Weak ADP Payroll Reading -- Market Talk

2 juil. 2025, 20:13 UTC

Market Talk

Oil Price Expectations Stable in Dallas Fed Survey -- Market Talk

2 juil. 2025, 19:09 UTC

Market Talk

Oil Futures Bounce in Defiance of Downbeat Data -- Market Talk

2 juil. 2025, 19:08 UTC

Market Talk

Dollar Trims Gains as Investors Brace for Cooling Jobs Market -- Market Talk

2 juil. 2025, 19:01 UTC

Market Talk

U.S. Natural Gas Ticks Up Ahead of Storage Data -- Market Talk

2 juil. 2025, 18:08 UTC

Market Talk

Fossil Fuels Rule Energy Roost As U.S. Marks Independence -- Market Talk

2 juil. 2025, 17:06 UTC

Acquisitions, Fusions, Rachats

BCE: Maple Leafs, Raptors Rights Access Through Long-Term Agreement With Rogers, Subject to League Approvals

2 juil. 2025, 17:05 UTC

Acquisitions, Fusions, Rachats

BCE: Access to Content Rights for Toronto Maple Leafs, Toronto Raptors on TSN Secured Through 2043/2044 Season

2 juil. 2025, 17:04 UTC

Acquisitions, Fusions, Rachats

BCE: Proceeds of MLSE Stake Sale to Support Financing of Acquisition of Ziply Fiber

2 juil. 2025, 17:04 UTC

Acquisitions, Fusions, Rachats

BCE Inc. Concludes Sale of Minority Stake in Maple Leaf Sports & Entertainment

2 juil. 2025, 17:02 UTC

Acquisitions, Fusions, Rachats

Rogers Communications: Now Largest Owner With 75% Interest in Maple Leaf Sports & Entertainment

2 juil. 2025, 17:02 UTC

Acquisitions, Fusions, Rachats

Rogers Communications Closes Deal to Buy BCE's 37.5% Stake in Maple Leaf Sports & Entertainment for C$4.7B

2 juil. 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

2 juil. 2025, 16:20 UTC

Market Talk

Cushing Crude Stock Slide Keeps Bid in WTI -- Market Talk

2 juil. 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

2 juil. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

2 juil. 2025, 16:11 UTC

Market Talk

Copper Prices Hold Higher on Supply Disruption, Tariff Uncertainty -- Market Talk

2 juil. 2025, 16:09 UTC

Market Talk

Gold Futures Rise, Recouping Some Losses -- Market Talk

2 juil. 2025, 15:59 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Centene, Apple, Adobe, Rigetti Computing, Greenbrier, and More -- Barrons.com

2 juil. 2025, 15:17 UTC

Market Talk

Oil Market to Keep Close Watch on U.S. Payrolls -- Market Talk

2 juil. 2025, 15:08 UTC

Market Talk

Luxury Sector Should Report a Slowdown -- Market Talk

2 juil. 2025, 15:00 UTC

Acquisitions, Fusions, Rachats

Glencore: Merger of Viterra With Bunge Global Closed

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

51.06% hausse

Prévisions sur 12 Mois

Moyen 45 USD  51.06%

Haut 60 USD

Bas 27 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

7 ratings

4

Achat

2

Maintien

1

Vente

Éléments financiers

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.